查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930260

製药生产设备市场规模、占有率、成长及全球产业分析：按类型、应用和地区划分的洞察与预测（2026-2034）

Pharmaceutical Manufacturing Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 126 Pages | 商品交期: 请询问到货日

价格

製药生产设备市场驱动因素

受药品需求成长、技术快速进步和监管框架日益严格的推动，全球製药生产设备市场持续稳定扩张。 2025年，该市场规模为236.7亿美元。报告显示，预计该市场将从2026年的251.4亿美元成长至2034年的462.1亿美元，在预测期（2026-2034年）内复合年增长率（CAGR）为7.9%。亚太地区在2025年引领全球市场，占总市占率的42.1%。

该市场竞争激烈，效率、合规性和技术创新在其中发挥着至关重要的作用。对生物製药、精准医疗和高科技製造解决方案的投资增加，显着提高了生产效率和合规性。此外，地缘政治趋势、全球贸易动态以及不断演变的环境、社会和治理 (ESG) 政策正在影响市场的长期扩张。

物联网与自动化的影响

物联网 (IoT) 和自动化技术的融合，透过提高品质控制、营运效率和法规遵从性，彻底改变了製药生产。新冠疫情加速了数位转型，推动了对快速、灵活的製造系统的需求，尤其是在疫苗和治疗药物方面。

支援物联网的设备能够实现即时监控、预测性维护和数据驱动的决策，而自动化则能减少对劳动力的依赖并最大限度地减少错误。这些进步正在推动对能够快速响应治疗药物需求波动的自适应製造解决方案的投资。例如，2024 年 10 月，Korber 和 AspenTech 合作，将 PAS-X MES 与 AspenTech Information 整合。这为製药厂商实现了无缝的现场整合和先进的资料管理。

製药生产设备市场趋势

影响市场趋势最显着的趋势之一是连续生产的快速普及，这缩短了生产时间，提高了效率，并降低了营运成本。此外，一次性使用技术 (SUT) 因其能够最大限度地降低污染风险并减少清洁和验证要求而日益普及。

先进的防伪技术，包括灭菌系统和追溯解决方案，也变得越来越重要。製造商越来越关注专为满足不断变化的监管和营运要求的连续灵活生产环境而设计的设备。 2024年6月，GEA集团推出了首款用于灌注培养的一次性碟片离心机，支援高强度连续细胞分离。

市场动态

市场驱动因素：

市场成长主要受仿製药、生物製品和活性药物成分（API）需求不断增长的驱动。 FDA和EMA等监管机构制定的监管要求对设备精度提出了更高的要求。外包给合约生产组织（CMO和CDMO）的增加以及工业4.0技术的日益普及进一步推动了市场成长。

市场限制因素：

巨额资本投资仍然是一个重大障碍，尤其对于中小型製造商而言。复杂的验证流程、监管合规成本以及地缘政治不稳定导致的供应链中断也阻碍了市场成长。

市场机会：

人们对永续和环保製造技术的兴趣日益浓厚，这带来了巨大的成长机会。节能减排设备的普及应用，以及向先进製造基础设施有限的新兴市场扩张，预计将支撑长期成长。

市场区隔分析

按设备类型划分，干燥机和造粒机市场占有率最大，这主要归功于其在先进配方製程中的关键作用。混合和搅拌设备预计将成长最快，到 2026 年将占 22.79% 的市场。

按生产类型划分，连续生产是成长最快的细分市场，预计复合年增长率将达到 8.27%。同时，预计到 2026 年，批量处理将占主导地位，市场占有率达到 58.23%。

按最终用户划分，CDMO（合约研发生产机构）细分市场占主导地位，这主要得益于广泛的外包和成本效益，预计其复合年增长率将达到 8.02%。

区域展望

预计亚太地区将引领市场，2025 年市场规模将达到 99.7 亿美元，到 2026 年将成长至 107.1 亿美元。预计中国市场规模将在 2026 年达到 43.6 亿美元，其次是印度和日本，分别为 24.5 亿美元和 14.5 亿美元。

预计北美市场规模将在 2026 年达到 77.8 亿美元，其次是欧洲，预计为 41.5 亿美元。受医疗基础设施不断扩展的推动，中东和非洲地区预计到 2026 年市场规模将达到 14.2 亿美元。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 宏观与微观经济指标
  • 驱动因素、限制因素、机会与趋势
  • 物联网和自动化的影响

第四章：竞争格局

  • 主要公司采用的商业策略
  • 主要公司的综合 SWOT 分析
  • 全球製药生产设备市场前 3-5 大公司的市占率/排名（2025 年）

章节5 全球製药生产设备市场规模估算与预测（2021-2034）：依细分市场划分

  • 主要发现
  • 依装置划分
    • 混合搅拌
    • 破碎
    • 干燥机和製粒机
    • 挤出机
    • 灌装和压片
    • 检定和灭菌
    • 包装等
  • 依生产类型划分
    • 连续式
    • 间歇式
  • 依最终用户划分
    • 大药厂
    • CDMO
    • 合约生产
    • CRO
  • 按地区划分
    • 北美
    • 南美
    • 欧洲
    • 亚太地区
    • 中东等地区非洲

第六章 北美製药生产设备市场规模估算与预测（2021-2034）：依细分市场划分

  • 依国家划分
    • 美国
    • 加拿大
    • 墨西哥

第七章 南美製药生产设备市场规模估算与预测（2021-2034）：依细分市场划分

  • 依国家划分
    • 巴西
    • 阿根廷
    • 其他南美国家

第八章 欧洲製药生产设备市场规模估算与预测（2021-2034）：依细分市场划分

  • 依国家/地区
    • 英国
    • 德国
    • 法国
    • 义大利
    • 瑞士
    • 西班牙
    • 其他欧洲国家

第九章：亚太地区製药生产设备市场规模估算与预测（2021-2034）：依细分市场划分

  • 依国家划分
    • 中国
    • 印度
    • 日本
    • 韩国
    • 东协
    • 其他亚太地区

第十章：中东与非洲製药生产设备市场规模估算与预测（2021-2034）：依细分市场划分

  • 依国家划分
    • 南非洲
    • 海湾合作委员会 (GCC)
    • 中东和非洲其他地区

第11章 主要十大公司的企业简介

  • GEA Group
  • Romaco Group
  • IMA Group
  • Syntegon Technology
  • Sartorius AG
  • ACG Group
  • Fette Compacting GmbH
  • Glatt
  • Paul Mueller Company
  • SED Pharma

第12章 主要点

Product Code: FBI112731

Growth Factors of pharmaceutical manufacturing equipment Market

The global pharmaceutical manufacturing equipment market is witnessing steady expansion driven by rising medicine demand, rapid technological advancements, and increasingly stringent regulatory frameworks. In 2025, the market was valued at USD 23.67 billion. According to the report, it is projected to grow from USD 25.14 billion in 2026 to USD 46.21 billion by 2034, registering a compound annual growth rate (CAGR) of 7.9% during the forecast period (2026-2034). The Asia Pacific region dominated the global market in 2025, accounting for 42.1% of the total share.

The market operates in a highly competitive environment where efficiency, regulatory compliance, and technological innovation play decisive roles. Rising investments in biopharmaceuticals, precision medicine, and high-tech manufacturing solutions are significantly improving production efficiency and compliance adherence. Additionally, geopolitical developments, global trade dynamics, and evolving Environmental, Social, and Governance (ESG) policies are influencing long-term market expansion.

Impact of IoT and Automation

The integration of Internet of Things (IoT) and automation technologies has transformed pharmaceutical manufacturing by improving quality control, operational efficiency, and regulatory compliance. The COVID-19 pandemic accelerated digital transformation, particularly increasing demand for high-speed and flexible manufacturing systems for vaccines and therapeutics.

IoT-enabled equipment supports real-time monitoring, predictive maintenance, and data-driven decision-making, while automation reduces labor dependency and minimizes errors. These advancements are driving investments in adaptable manufacturing solutions capable of responding swiftly to fluctuating therapeutic demand. For instance, in October 2024, Korber and AspenTech partnered to integrate PAS-X MES with AspenTech Inmation, enabling seamless shopfloor integration and advanced data management for pharmaceutical manufacturers.

Pharmaceutical Manufacturing Equipment Market Trends

One of the most prominent trends shaping the market is the rapid adoption of continuous manufacturing, which reduces production time, enhances efficiency, and lowers operational costs. Additionally, Single-Use Technologies (SUT) are gaining traction due to their ability to minimize contamination risks and reduce cleaning and validation requirements.

Advanced anti-counterfeiting technologies, including sterilization systems and track-and-trace solutions, are also gaining importance. Manufacturers are increasingly focusing on equipment designed for continuous and flexible manufacturing environments, aligning with evolving regulatory and operational requirements. In June 2024, GEA Group introduced the first single-use disc centrifuge for perfusion, supporting high-intensity continuous cell separation.

Market Dynamics

Market Drivers:

Growth is driven by rising demand for generic drugs, biologics, and Active Pharmaceutical Ingredients (API). Regulatory requirements set by authorities such as the FDA and EMA necessitate advanced precision equipment. Increased outsourcing to contract manufacturing organizations (CMOs and CDMOs) and growing adoption of Industry 4.0 technologies further support market expansion.

Market Restraints:

High capital investment remains a significant barrier, particularly for small and mid-sized manufacturers. Complex validation processes, regulatory compliance costs, and supply chain disruptions caused by geopolitical instability also pose challenges to market growth.

Market Opportunities:

The growing focus on sustainable and green manufacturing technologies presents major opportunities. Energy-efficient, waste-reducing equipment and expansion into emerging markets with limited advanced manufacturing infrastructure are expected to support long-term growth.

Segmentation Analysis

By equipment type, the dryer and granulator segment holds the largest market share due to its critical role in advanced formulation processes. Mixing and blending equipment is expected to witness the fastest growth, holding 22.79% market share in 2026.

By manufacturing type, continuous manufacturing is the fastest-growing segment, projected to grow at a CAGR of 8.27%, while batch processing is expected to dominate with 58.23% market share in 2026.

By end user, the CDMO segment leads the market, driven by extensive outsourcing and cost efficiency, and is expected to grow at a CAGR of 8.02%.

Regional Outlook

In 2025, Asia Pacific led the market with a value of USD 9.97 billion, increasing to USD 10.71 billion in 2026. China is expected to reach USD 4.36 billion in 2026, while India and Japan are projected at USD 2.45 billion and USD 1.45 billion, respectively.

North America is expected to reach USD 7.78 billion in 2026, followed by Europe at USD 4.15 billion. The Middle East & Africa is projected to reach USD 1.42 billion in 2026, supported by expanding healthcare infrastructure.

Conclusion

In conclusion, the pharmaceutical manufacturing equipment market is poised for sustained growth, expanding from USD 23.67 billion in 2025 to USD 46.21 billion by 2034. The convergence of automation, IoT, continuous manufacturing, and sustainable technologies is reshaping pharmaceutical production globally. Despite challenges such as high capital investment and regulatory complexities, strong demand for advanced medicines, API manufacturing, and outsourcing services ensures a positive long-term outlook for the market.

Segmentation By Equipment

  • Mixing & Blending
  • Milling
  • Dryer & Granulators
  • Extrusion
  • Filling & Compression
  • Inspection & Sterilization
  • Packaging, etc.

By Manufacturing Type

  • Continuous
  • Batch

By End User

  • Large Scale Pharma
  • CDMO
  • CMO
  • CRO

By Region

  • North America (By Equipment, By Manufacturing Type, By End User, and By Country)
    • U.S. (By End User)
    • Canada (By End User)
    • Mexico (By End User)
  • Europe (By Equipment, By End User, and By Country)
    • U.K. (By End User)
    • Germany (By End User)
    • France (By End User)
    • Italy (By End User)
    • Switzerland (By End User)
    • Spain (By End User)
    • Rest of Europe
  • Asia Pacific (By Equipment, By End User, and By Country)
    • China (By End User)
    • India (By End User)
    • Japan (By End User)
    • South Korea (By End User)
    • ASEAN (By End User)
    • Rest of Asia Pacific
  • Middle East & Africa (By Equipment, By End User, and By Country)
    • South Africa (By End User)
    • GCC (By End User)
    • Rest of Middle East & Africa
  • South America (By Equipment, By End User, and By Country)
    • Brazil (By End User)
    • Argentina (By End User)
    • Rest of South America

Key Market Players Profiled in the Report GEA Group AG (Germany), Syntegon Technology GmbH (Germany), Sartorius AG (Germany), ACG (India), IMA Group (Italy), Glatt GmbH (Germany), Romaco Group (Germany), Fette Compacting (Germany), Paul Mueller (U.S.), SED Pharma (China), etc.

Table of Content

1. Introduction

  • 1.1. Definition, By Segment
  • 1.2. Research Methodology/Approach
  • 1.3. Data Sources

2. Executive Summary

3. Market Dynamics

  • 3.1. Macro and Micro Economic Indicators
  • 3.2. Drivers, Restraints, Opportunities and Trends
  • 3.3. Impact of IoT and Automation

4. Competition Landscape

  • 4.1. Business Strategies Adopted by Key Players
  • 4.2. Consolidated SWOT Analysis of Key Players
  • 4.3. Global Pharmaceutical Manufacturing Equipment Key Players [Top 3-5] Market Share/Ranking, 2025

5. Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 5.1. Key Findings
  • 5.2. By Equipment (USD)
    • 5.2.1. Mixing & Blending
    • 5.2.2. Milling
    • 5.2.3. Dryer & Granulators
    • 5.2.4. Extrusion
    • 5.2.5. Filling & Compression
    • 5.2.6. Inspection & Sterilization
    • 5.2.7. Packaging, etc.
  • 5.3. By Manufacturing Type (USD)
    • 5.3.1. Continuous
    • 5.3.2. Batch
  • 5.4. By End User (USD)
    • 5.4.1. Large Scale Pharmas
    • 5.4.2. CDMO
    • 5.4.3. CMO
    • 5.4.4. CRO
  • 5.5. By Region (USD)
    • 5.5.1. North America
    • 5.5.2. South America
    • 5.5.3. Europe
    • 5.5.4. Asia Pacific
    • 5.5.5. Middle East & Africa

6. North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 6.1. Key Findings
  • 6.2. By Equipment (USD)
    • 6.2.1. Mixing & Blending
    • 6.2.2. Milling
    • 6.2.3. Dryer & Granulators
    • 6.2.4. Extrusion
    • 6.2.5. Filling & Compression
    • 6.2.6. Inspection & Sterilization
    • 6.2.7. Packaging, etc.
  • 6.3. By Manufacturing Type (USD)
    • 6.3.1. Continuous
    • 6.3.2. Batch
  • 6.4. By End User (USD)
    • 6.4.1. Large Scale Pharmas
    • 6.4.2. CDMO
    • 6.4.3. CMO
    • 6.4.4. CRO
  • 6.5. By Country (USD)
    • 6.5.1. United States
      • 6.5.1.1. By End User
    • 6.5.2. Canada
      • 6.5.2.1. By End User
    • 6.5.3. Mexico
      • 6.5.3.1. By End User

7. South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 7.1. Key Findings
  • 7.2. By Equipment (USD)
    • 7.2.1. Mixing & Blending
    • 7.2.2. Milling
    • 7.2.3. Dryer & Granulators
    • 7.2.4. Extrusion
    • 7.2.5. Filling & Compression
    • 7.2.6. Inspection & Sterilization
    • 7.2.7. Packaging, etc.
  • 7.3. By Manufacturing Type (USD)
    • 7.3.1. Continuous
    • 7.3.2. Batch
  • 7.4. By End User (USD)
    • 7.4.1. Large Scale Pharmas
    • 7.4.2. CDMO
    • 7.4.3. CMO
    • 7.4.4. CRO
  • 7.5. By Country (USD)
    • 7.5.1. Brazil
      • 7.5.1.1. By End User
    • 7.5.2. Argentina
      • 7.5.2.1. By End User
    • 7.5.3. Rest of South America

8. Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 8.1. Key Findings
  • 8.2. By Equipment (USD)
    • 8.2.1. Mixing & Blending
    • 8.2.2. Milling
    • 8.2.3. Dryer & Granulators
    • 8.2.4. Extrusion
    • 8.2.5. Filling & Compression
    • 8.2.6. Inspection & Sterilization
    • 8.2.7. Packaging, etc.
  • 8.3. By Manufacturing Type (USD)
    • 8.3.1. Continuous
    • 8.3.2. Batch
  • 8.4. By End User (USD)
    • 8.4.1. Large Scale Pharmas
    • 8.4.2. CDMO
    • 8.4.3. CMO
    • 8.4.4. CRO
  • 8.5. By Country (USD)
    • 8.5.1. United Kingdom
      • 8.5.1.1. By End User
    • 8.5.2. Germany
      • 8.5.2.1. By End User
    • 8.5.3. France
      • 8.5.3.1. By End User
    • 8.5.4. Italy
      • 8.5.4.1. By End User
    • 8.5.5. Switzerland
      • 8.5.5.1. By End User
    • 8.5.6. Spain
      • 8.5.6.1. By End User
    • 8.5.7. Rest of Europe

9. Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 9.1. Key Findings
  • 9.2. By Equipment (USD)
    • 9.2.1. Mixing & Blending
    • 9.2.2. Milling
    • 9.2.3. Dryer & Granulators
    • 9.2.4. Extrusion
    • 9.2.5. Filling & Compression
    • 9.2.6. Inspection & Sterilization
    • 9.2.7. Packaging, etc.
  • 9.3. By Manufacturing Type (USD)
    • 9.3.1. Continuous
    • 9.3.2. Batch
  • 9.4. By End User (USD)
    • 9.4.1. Large Scale Pharmas
    • 9.4.2. CDMO
    • 9.4.3. CMO
    • 9.4.4. CRO
  • 9.5. By Country (USD)
    • 9.5.1. China
      • 9.5.1.1. By End User
    • 9.5.2. India
      • 9.5.2.1. By End User
    • 9.5.3. Japan
      • 9.5.3.1. By End User
    • 9.5.4. South Korea
      • 9.5.4.1. By End User
    • 9.5.5. ASEAN
      • 9.5.5.1. By End User
    • 9.5.6. Rest of Asia Pacific

10. Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 10.1. Key Findings
  • 10.2. By Equipment (USD)
    • 10.2.1. Mixing & Blending
    • 10.2.2. Milling
    • 10.2.3. Dryer & Granulators
    • 10.2.4. Extrusion
    • 10.2.5. Filling & Compression
    • 10.2.6. Inspection & Sterilization
    • 10.2.7. Packaging, etc.
  • 10.3. By Manufacturing Type (USD)
    • 10.3.1. Continuous
    • 10.3.2. Batch
  • 10.4. By End User (USD)
    • 10.4.1. Large Scale Pharmas
    • 10.4.2. CDMO
    • 10.4.3. CMO
    • 10.4.4. CRO
  • 10.5. By Country (USD)
    • 10.5.1. South Africa
      • 10.5.1.1. By End User
    • 10.5.2. GCC
      • 10.5.2.1. By End User
    • 10.5.3. Rest of MEA

11. Company Profiles for Top 10 Players (Based on data availability in public domain and/or on paid databases)

  • 11.1. GEA Group
    • 11.1.1. Overview
      • 11.1.1.1. Key Management
      • 11.1.1.2. Headquarters
      • 11.1.1.3. Offerings/Business Segments
    • 11.1.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.1.2.1. Employee Size
      • 11.1.2.2. Past and Current Revenue
      • 11.1.2.3. Geographical Share
      • 11.1.2.4. Business Segment Share
      • 11.1.2.5. Recent Developments
  • 11.2. Romaco Group
    • 11.2.1. Overview
      • 11.2.1.1. Key Management
      • 11.2.1.2. Headquarters
      • 11.2.1.3. Offerings/Business Segments
    • 11.2.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.2.2.1. Employee Size
      • 11.2.2.2. Past and Current Revenue
      • 11.2.2.3. Geographical Share
      • 11.2.2.4. Business Segment Share
      • 11.2.2.5. Recent Developments
  • 11.3. IMA Group
    • 11.3.1. Overview
      • 11.3.1.1. Key Management
      • 11.3.1.2. Headquarters
      • 11.3.1.3. Offerings/Business Segments
    • 11.3.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.3.2.1. Employee Size
      • 11.3.2.2. Past and Current Revenue
      • 11.3.2.3. Geographical Share
      • 11.3.2.4. Business Segment Share
      • 11.3.2.5. Recent Developments
  • 11.4. Syntegon Technology
    • 11.4.1. Overview
      • 11.4.1.1. Key Management
      • 11.4.1.2. Headquarters
      • 11.4.1.3. Offerings/Business Segments
    • 11.4.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.4.2.1. Employee Size
      • 11.4.2.2. Past and Current Revenue
      • 11.4.2.3. Geographical Share
      • 11.4.2.4. Business Segment Share
      • 11.4.2.5. Recent Developments
  • 11.5. Sartorius AG
    • 11.5.1. Overview
      • 11.5.1.1. Key Management
      • 11.5.1.2. Headquarters
      • 11.5.1.3. Offerings/Business Segments
    • 11.5.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.5.2.1. Employee Size
      • 11.5.2.2. Past and Current Revenue
      • 11.5.2.3. Geographical Share
      • 11.5.2.4. Business Segment Share
      • 11.5.2.5. Recent Developments
  • 11.6. ACG Group
    • 11.6.1. Overview
      • 11.6.1.1. Key Management
      • 11.6.1.2. Headquarters
      • 11.6.1.3. Offerings/Business Segments
    • 11.6.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.6.2.1. Employee Size
      • 11.6.2.2. Past and Current Revenue
      • 11.6.2.3. Geographical Share
      • 11.6.2.4. Business Segment Share
      • 11.6.2.5. Recent Developments
  • 11.7. Fette Compacting GmbH
    • 11.7.1. Overview
      • 11.7.1.1. Key Management
      • 11.7.1.2. Headquarters
      • 11.7.1.3. Offerings/Business Segments
    • 11.7.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.7.2.1. Employee Size
      • 11.7.2.2. Past and Current Revenue
      • 11.7.2.3. Geographical Share
      • 11.7.2.4. Business Segment Share
      • 11.7.2.5. Recent Developments
  • 11.8. Glatt
    • 11.8.1. Overview
      • 11.8.1.1. Key Management
      • 11.8.1.2. Headquarters
      • 11.8.1.3. Offerings/Business Segments
    • 11.8.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.8.2.1. Employee Size
      • 11.8.2.2. Past and Current Revenue
      • 11.8.2.3. Geographical Share
      • 11.8.2.4. Business Segment Share
      • 11.8.2.5. Recent Developments
  • 11.9. Paul Mueller Company
    • 11.9.1. Overview
      • 11.9.1.1. Key Management
      • 11.9.1.2. Headquarters
      • 11.9.1.3. Offerings/Business Segments
    • 11.9.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.9.2.1. Employee Size
      • 11.9.2.2. Past and Current Revenue
      • 11.9.2.3. Geographical Share
      • 11.9.2.4. Business Segment Share
      • 11.9.2.5. Recent Developments
  • 11.10. SED Pharma
    • 11.10.1. Overview
      • 11.10.1.1. Key Management
      • 11.10.1.2. Headquarters
      • 11.10.1.3. Offerings/Business Segments
    • 11.10.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.10.2.1. Employee Size
      • 11.10.2.2. Past and Current Revenue
      • 11.10.2.3. Geographical Share
      • 11.10.2.4. Business Segment Share
      • 11.10.2.5. Recent Developments

12. Key Takeaways

List of Tables

  • Table 1: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 2: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 3: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 4: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 5: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Region, 2021 - 2034
  • Table 6: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 7: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 8: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 9: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 10: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 11: U.S. Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 12: Canada Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 13: Mexico Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 14: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 15: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 16: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 17: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 18: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 19: U.K. Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 20: Germany Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 21: France Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 22: Italy Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 23: Switzerland Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 24: Spain Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 25: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 26: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 27: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 28: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 29: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 30: China Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 31: India Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 32: Japan Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 33: South Korea Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 34: ASEAN Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 35: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 36: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 37: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 38: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 39: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 40: South Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 41: GCC Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 42: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 43: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 44: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 45: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 46: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 47: Brazil Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 48: Argentina Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034

List of Figures

  • Figure 1: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 2: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 3: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 4: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 5: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Region, 2025 and 2034
  • Figure 6: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 7: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 8: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 9: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 10: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 11: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 12: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 13: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 14: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 15: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 16: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 17: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 18: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 19: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 20: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 21: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 22: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 23: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 24: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 25: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 26: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 27: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 28: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 29: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 30: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 31: Global Pharmaceutical Manufacturing Equipment Market Key Players' Market Revenue Share(%), 2025